Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.

Sponsor
Grigore T. Popa University of Medicine and Pharmacy (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05705011
Collaborator
(none)
240
1
48.4
5

Study Details

Study Description

Brief Summary

This observational study explores the impact of cognitive impairment and frailty in older adults with advanced chronic kidney disease ].

The main question[s] it aims to answer are:
  • What determines the time to initiate dialysis? Cognitive impairment or frailty?

  • What does predict the time to death? Presence of frailty or cognitive impairment?

  • What does correlate strongly with time-low health-related quality of life? frailty or cognitive impairment?

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    240 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease: Mortality and Dialysis Initiation, a Prospective Cohort Study.
    Actual Study Start Date :
    Mar 1, 2019
    Anticipated Primary Completion Date :
    Feb 5, 2023
    Anticipated Study Completion Date :
    Mar 12, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Time to death [36 months]

      The time from the assessment moment to death of an older adult with advanced CKD ( CKD stage 4 and 5).

    2. Time to initiate dialysis. [36 months]

      The time from the assessment moment to start dialysis of an older adult with advanced CKD (

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients age 65 years or older.

    • CKD stage 4 and 5 who were identified by two consecutive measurements of estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 separated by more than 3 months.

    Exclusion Criteria:
    • Patients younger than 65 years old.

    • Chronic kidney disease stages 1,2, and 3.

    • Dialysis dependence

    • History of kidney transplantation.

    • Initial visit with the health care provider.

    • Recent acute kidney injury.

    • Patients who had been hospitalized for more than 2 months before the visit (because long hospitalization might affect the degree of frailty)

    • Patients with myocardial infarction and cerebrovascular accident 3 months before the assessment

    • Patients who are blind or with limb amputation.

    • Patients who refuse to participate.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Medicine and Pharmacy "Grigore T. Popa" Iasi Romania 700115

    Sponsors and Collaborators

    • Grigore T. Popa University of Medicine and Pharmacy

    Investigators

    • Principal Investigator: Hani Hussien, MD, University of Medicine and Pharmacy "Grigore T. Popa" - IaČ™i

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Hani Hussien, Doctor, Grigore T. Popa University of Medicine and Pharmacy
    ClinicalTrials.gov Identifier:
    NCT05705011
    Other Study ID Numbers:
    • Nephrogeriatrics
    First Posted:
    Jan 30, 2023
    Last Update Posted:
    Jan 30, 2023
    Last Verified:
    Jan 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Hani Hussien, Doctor, Grigore T. Popa University of Medicine and Pharmacy
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 30, 2023